Search clinical trials for: Palbociclib Rabeprazole
Total 564 results
-
SOLTI Breast Cancer Research GroupPfizerCompleted
-
Dana-Farber Cancer InstitutePfizerCompletedHuman Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone Receptor (HR)-Positive Breast CancerUnited States
-
Merck Sharp & Dohme LLCCompletedFoot Infections in Diabetic Patients
-
Xijing Hospital of Digestive DiseasesCompletedDyspepsia | Gastric Cancer | Helicobacter Pylori Infection | Chronic GastritisChina
-
Clinical Centre of SerbiaUnknownHelicobacter Pylori Infection
-
Second Affiliated Hospital, School of Medicine,...RecruitingHelicobacter Pylori InfectionChina
-
Biolipox ABCompletedAllergic RhinitisSweden
-
ETOP IBCSG Partners FoundationBreast International GroupCompletedPalbociclib in Molecularly Characterized ER-positive/HER2-negative Metastatic Breast Cancer (PYTHIA)Metastatic Breast CancerUnited Kingdom, Belgium, Italy
-
European Organisation for Research and Treatment...Active, not recruitingCarcinoma, Squamous Cell of Head and NeckFrance, Spain, Belgium, Italy, United Kingdom
-
PfizerCompletedBreast CancerKorea, Republic of, United States, Spain, Germany, Ireland, Hungary, Canada, France, Italy, Russian Federation, South Africa, Ukraine
-
PfizerRecruitingHealthy ParticipantsUnited States
-
Tianjin Medical University Cancer Institute and...RecruitingBreast Cancer | Fulvestrant | PalbociclibChina
-
Hamdy A. AzimRecruitingPalbocIclib in PreMenopausal Women With ER Positive/HER-2 Negative MetAstatic Breast Cancer (FATIMA)Metastatic Breast CancerSouth Africa
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Breast CancerUnited States
-
University Hospital Inselspital, BerneDaiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyTerminatedCOVID-19 | SARS-CoV InfectionBelgium, Switzerland, Italy
-
Haihe Biopharma Co., Ltd.Not yet recruiting
-
PfizerArvinas Estrogen Receptor, Inc.Active, not recruitingBreast CancerSpain, United States, China, Japan, Australia, Italy, Switzerland, Hungary, Brazil, Slovakia
-
Hoffmann-La RocheActive, not recruitingBreast CancerUnited States, Korea, Republic of, United Kingdom, Australia, Belgium, China, Denmark, France, Hungary, Portugal, Spain, Taiwan, Thailand, Canada, Italy, Argentina, Brazil, Poland, Singapore, Germany, Greece, Hong Kong, Ukraine, Russian... and more
-
Theodoros FoukakisTerminatedBreast Cancer MetastaticSweden, United Kingdom
-
Relay Therapeutics, Inc.Active, not recruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Solid Tumor, Adult | HER2-negative Breast Cancer | Hormone Receptor Positive Tumor | Unresectable Solid Tumor | PIK3CA MutationUnited States
-
Hoffmann-La RocheCompletedEarly Breast CancerSpain, Korea, Republic of, Australia, Taiwan, Ukraine, Poland, Russian Federation, United States, Germany, Brazil, Hungary
-
UCB PharmaCompleted
-
Fudan UniversityRecruitingHER2-positive Breast Cancer | Estrogen Receptor-positive Breast CancerChina
-
Criterium, Inc.Recruiting
-
Boehringer IngelheimCompletedNon-alcoholic Fatty Liver DiseaseJapan
-
First Affiliated Hospital Xi'an Jiaotong UniversityRecruiting
-
German Breast GroupPfizer; AMS Advanced Medical Services GmbHRecruitingMetastatic Breast CancerGermany
-
Xijing Hospital of Digestive DiseasesRecruitingHelicobacter Pylori Infection | Chronic GastritisChina
-
BiogenCompleted
-
HutchmedCompletedRelapsed or Refractory LymphomaUnited States
-
Abramson Cancer Center at Penn MedicineActive, not recruitingAdvanced Breast Cancer | Metastatic Breast Cancer | BRCA1 Mutation | BRCA2 Mutation | Locally Advanced Breast CancerUnited States
-
Oana Danciu, MDPfizer; Big Ten Cancer Research ConsortiumActive, not recruitingMetastatic Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Estrogen Receptor Positive Breast Cancer | Progesterone Receptor Positive TumorUnited States
-
Bristol-Myers SquibbCompletedCancer | Breast CancerBelgium, United States, Spain, France, Germany, Australia, Canada, Puerto Rico
-
University Medical Center GroningenNot yet recruitingRenal Cell Carcinoma | Breast Carcinoma | Thyroid Carcinoma | Ovarian Carcinoma | Endometrium CarcinomaNetherlands
-
Dana-Farber Cancer InstitutePfizerActive, not recruiting
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast CancerUnited States, Italy, Korea, Republic of, Canada, Germany, United Kingdom, Australia, Belgium, Brazil, China, Denmark, France, Hong Kong, Portugal, Spain, Taiwan, Turkey, Japan, Argentina, Mexico, Israel, Poland, Russian Federation, A... and more
-
Memorial Sloan Kettering Cancer CenterContext Therapeutics Inc.WithdrawnMetastatic Breast Cancer | Unresectable Breast CancerUnited States
-
Istituti Clinici Scientifici Maugeri SpACompletedFemale | Neoplasm Malignant | BreastItaly
-
Fondazione MichelangeloCompleted
-
PfizerCompletedMultiple MyelomaUnited States, Germany, Czech Republic
-
Chang Gung Memorial HospitalCompletedHelicobacter Pylori InfectionTaiwan
-
MedSIRPfizerCompletedBreast Cancer | Advanced Breast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastSpain, Germany, France, United Kingdom, Italy, Slovenia
-
Icahn School of Medicine at Mount SinaiNYU Langone Health; Weill Medical College of Cornell University; Herbert Irving...Active, not recruitingAnastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic BreastBreast Neoplasms | Breast DiseasesUnited States
-
Peter MacCallum Cancer Centre, AustraliaTerminated
-
MedSIRCompletedMetastatic Breast CancerSpain, Czechia, France, Germany, Italy, Russian Federation, United Kingdom
-
NSABP Foundation IncPfizer; Genomic Health®, Inc.CompletedBreast CancerUnited States, Canada
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingHER2/Neu Negative | Estrogen Receptor-positive Breast Cancer | Stage IV Breast Cancer AJCC v6 and v7United States
-
Fondazione Sandro PitiglianiCompleted
-
Canadian Network for Observational Drug Effect...Canadian Institutes of Health Research (CIHR); Drug Safety and Effectiveness...CompletedGastroesophageal Reflux Disease (GERD) | Community-acquired PneumoniaCanada